Status:
TERMINATED
Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Uncontrolled Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Therapeutic compliance is defined as the degree of coincidence between a person's behavior and prescribing advice given by his or her physician. According to the World Health Organization (WHO), "insu...
Eligibility Criteria
Inclusion
- patient treated with diuretics and / or beta-blockers and / or calcium-blockers and / or ACE inhibitors and / or sartans
- Holter blood pressure total average of 24h greater than 135/85 mmHg or a daytime average greater than 140/90 mmHg or a nighttime average greater than 125/75 mmHg.
- informed consent given
Exclusion
- Adults with severe hypertension (BP ≥ 180/110 mmHg) with or without organ failure requiring therapeutic adaptation
- Adults unable to comply with study procedures
- Patients who do not wish to receive generic drugs.
Key Trial Info
Start Date :
December 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 23 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03348878
Start Date
December 16 2019
End Date
March 23 2022
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Louis Pradel
Bron, France